Hind Rectifiers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 11, 2025, 6:14 pm

Quick Insight

Hind Rectifiers Ltd, operating within the electronics equipment sector, presents a compelling yet complex investment case. With a current share price of ₹1,712 and a market capitalization of ₹2,940 crore, the company exhibits a high P/E ratio of 68.1, suggesting that investors are pricing in significant growth expectations. Its robust ROE of 25.7% and ROCE of 21.6% indicate efficient use of equity and capital, respectively. However, the operating profit margin (OPM) of 11% and a relatively high P/BV of 8.29x may raise concerns regarding valuation sustainability. Moreover, with borrowings of ₹164 crore against reserves of ₹157 crore, the company is in a delicate financial position, reflected in its CCC of 110 days. Given these metrics, prospective investors should weigh the high growth potential against the elevated valuation and leverage risks, making a cautious approach advisable.

Competitors of Hind Rectifiers Ltd

All Competitor Stocks of Hind Rectifiers Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:05 pm

Below is a detailed analysis of the quarterly data for Hind Rectifiers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 215.00 Cr.. The value appears strong and on an upward trend. It has increased from 185.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 30.00 Cr..
• For Expenses, as of Jun 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.00 Cr. (Mar 2025) to 190.00 Cr., marking an increase of 25.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Interest, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 28.00% (Mar 2025) to 29.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.46. The value appears strong and on an upward trend. It has increased from 5.91 (Mar 2025) to 7.46, marking an increase of 1.55.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:42 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 3:06 pm

Below is a detailed analysis of the balance sheet data for Hind Rectifiers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 121.00 Cr. (Mar 2024) to 157.00 Cr., marking an increase of 36.00 Cr..
• For Borrowings, as of Mar 2025, the value is 164.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 135.00 Cr. (Mar 2024) to 164.00 Cr., marking an increase of 29.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 93.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.00 Cr. (Mar 2024) to 93.00 Cr., marking an increase of 22.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 418.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 331.00 Cr. (Mar 2024) to 418.00 Cr., marking an increase of 87.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 107.00 Cr.. The value appears strong and on an upward trend. It has increased from 90.00 Cr. (Mar 2024) to 107.00 Cr., marking an increase of 17.00 Cr..
• For CWIP, as of Mar 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2024) to 12.00 Cr., marking a decrease of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 298.00 Cr.. The value appears strong and on an upward trend. It has increased from 219.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 79.00 Cr..
• For Total Assets, as of Mar 2025, the value is 418.00 Cr.. The value appears strong and on an upward trend. It has increased from 331.00 Cr. (Mar 2024) to 418.00 Cr., marking an increase of 87.00 Cr..

However, the Borrowings (164.00 Cr.) are higher than the Reserves (157.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hind Rectifiers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 7.30. This value is within the healthy range. It has increased from -3.84 (Mar 23) to 7.30, marking an increase of 11.14.
• For Diluted EPS (Rs.), as of Mar 24, the value is 7.28. This value is within the healthy range. It has increased from -3.84 (Mar 23) to 7.28, marking an increase of 11.12.
• For Cash EPS (Rs.), as of Mar 24, the value is 11.64. This value is within the healthy range. It has increased from -0.71 (Mar 23) to 11.64, marking an increase of 12.35.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 72.66. It has increased from 65.24 (Mar 23) to 72.66, marking an increase of 7.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 72.66. It has increased from 65.24 (Mar 23) to 72.66, marking an increase of 7.42.
• For Dividend / Share (Rs.), as of Mar 24, the value is 1.20. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 1.20, marking an increase of 1.20.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 301.99. It has increased from 209.71 (Mar 23) to 301.99, marking an increase of 92.28.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 26.17. This value is within the healthy range. It has increased from 8.96 (Mar 23) to 26.17, marking an increase of 17.21.
• For PBIT / Share (Rs.), as of Mar 24, the value is 21.83. This value is within the healthy range. It has increased from 5.96 (Mar 23) to 21.83, marking an increase of 15.87.
• For PBT / Share (Rs.), as of Mar 24, the value is 10.32. This value is within the healthy range. It has increased from -5.07 (Mar 23) to 10.32, marking an increase of 15.39.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 7.30. This value is within the healthy range. It has increased from -3.72 (Mar 23) to 7.30, marking an increase of 11.02.
• For PBDIT Margin (%), as of Mar 24, the value is 8.66. This value is below the healthy minimum of 10. It has increased from 4.27 (Mar 23) to 8.66, marking an increase of 4.39.
• For PBIT Margin (%), as of Mar 24, the value is 7.22. This value is below the healthy minimum of 10. It has increased from 2.84 (Mar 23) to 7.22, marking an increase of 4.38.
• For PBT Margin (%), as of Mar 24, the value is 3.41. This value is below the healthy minimum of 10. It has increased from -2.41 (Mar 23) to 3.41, marking an increase of 5.82.
• For Net Profit Margin (%), as of Mar 24, the value is 2.41. This value is below the healthy minimum of 5. It has increased from -1.77 (Mar 23) to 2.41, marking an increase of 4.18.
• For Return on Networth / Equity (%), as of Mar 24, the value is 10.04. This value is below the healthy minimum of 15. It has increased from -5.69 (Mar 23) to 10.04, marking an increase of 15.73.
• For Return on Capital Employeed (%), as of Mar 24, the value is 23.65. This value is within the healthy range. It has increased from 7.21 (Mar 23) to 23.65, marking an increase of 16.44.
• For Return On Assets (%), as of Mar 24, the value is 3.77. This value is below the healthy minimum of 5. It has increased from -2.17 (Mar 23) to 3.77, marking an increase of 5.94.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.21 (Mar 23) to 0.18, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.04. This value exceeds the healthy maximum of 1. It has increased from 0.93 (Mar 23) to 1.04, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.66. It has increased from 1.33 (Mar 23) to 1.66, marking an increase of 0.33.
• For Current Ratio (X), as of Mar 24, the value is 1.21. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 23) to 1.21, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.61 (Mar 23) to 0.64, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.03. This value is within the healthy range. It has increased from 3.42 (Mar 23) to 4.03, marking an increase of 0.61.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.52. This value is within the healthy range. It has increased from 1.89 (Mar 23) to 3.52, marking an increase of 1.63.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.53. This value is below the healthy minimum of 3. It has increased from 1.54 (Mar 23) to 2.53, marking an increase of 0.99.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,159.34. It has increased from 436.09 (Mar 23) to 1,159.34, marking an increase of 723.25.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.24. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 2.24, marking an increase of 1.03.
• For EV / EBITDA (X), as of Mar 24, the value is 25.85. This value exceeds the healthy maximum of 15. It has decreased from 28.41 (Mar 23) to 25.85, marking a decrease of 2.56.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.99. This value is within the healthy range. It has increased from 0.92 (Mar 23) to 1.99, marking an increase of 1.07.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 8.29. This value exceeds the healthy maximum of 3. It has increased from 2.98 (Mar 23) to 8.29, marking an increase of 5.31.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.99. This value is within the healthy range. It has increased from 0.92 (Mar 23) to 1.99, marking an increase of 1.07.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 23) to 0.01, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness